Gelonghui, May 8 | Saisheng Pharmaceutical (300485.SZ) said on the investor interactive platform that the company has genetic engineering and biological extraction technology, which can be applied to synthetic biology. Currently, the company is not involved in this business. Among the investment projects initiated by the company, 3 companies involved synthetic biology: Shanxi Kaisheng Biotechnology Co., Ltd., Chengdu Yatu Biotechnology Co., Ltd., and Like Times (Wuhan) Biotechnology Co., Ltd.
赛升药业(300485.SZ)：具备基因工程和生物提取技术，可应用于合成生物学方面，目前公司不涉及该业务
Saisheng Pharmaceutical (300485.SZ): It has genetic engineering and biological extraction technology, and can be applied to synthetic biology. Currently, the company is not involved in this business
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.